Product Images Ilaris
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Ilaris NDC 0078-0734 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
ILARIS Ry is a subcutaneous injection medication with a concentration of 150 mg/mL produced by Novartis. It comes in a single-dose vial, and any unused medication should be discarded. The medication guide enclosed with the package should be thoroughly reviewed before administration. Storage of the medication should be within the temperature range of 2-8 degrees Celsius.*
This seems to be a graph displaying the Kaplan-Meier estimate for the treatment group (ACZ885) and a control group (Placebo) in weeks using percentages. It appears to show the number of patients at risk and the number of weeks in Part II of the study. The ACZ885 group seems to have more patients at risk than the placebo group at each week. The text is only giving numerical data and no context is provided.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.